Context Therapeutics Inc.(CNTX)

Biotechnology · Philadelphia, PA

$0.34+0.00 (+0.71%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T13:31:04.416Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:31:04.416Z.

Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 31,137,853
Total debt · period ending 2026-06-30: 244,992
Cash · period ending 2026-06-30: 42,990,371
TTM operating income · period ending 2026-06-30: -48,726,416

FMP input reference: c88c4f39e0f2b8ce509c05ad310ef4a925915372bb385716b1b31bbca6f45484

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNTX EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

CNTX Competitors' EV/EBIT Ratio

CNTX

Context Therapeutics Inc.

Current

Market Cap

$31.14M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs CNTX

Market Cap

$31.11M

EV/EBIT Ratio

N/A

TTM Avg

0.37x

3Y Avg

0.82x

5Y Avg

0.82x

BDMD

Baird Medical Investment Holdings Limited

vs CNTX

Market Cap

$30.81M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs CNTX

Market Cap

$32.55M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs CNTX

Market Cap

$31.35M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATYR

aTyr Pharma, Inc.

vs CNTX

Market Cap

$28.43M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs CNTX

Market Cap

$33.79M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs CNTX

Market Cap

$33.85M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs CNTX

Market Cap

$29.24M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs CNTX

Market Cap

$36.26M

EV/EBIT Ratio

N/A

TTM Avg

50.30x

3Y Avg

467.13x

5Y Avg

265.91x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Context Therapeutics Inc. (CNTX)	$31.14M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$31.11M	N/A	0.37x	0.82x	0.82x
Baird Medical Investment Holdings Limited (BDMD)vs ›	$30.81M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.55M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.35M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$28.43M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.79M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$33.85M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$29.24M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$36.26M	N/A	50.30x	467.13x	265.91x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

CNTX EV/EBIT Ratio Metrics

CNTX Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics